The six Tottenham matches which Destiny Udogie will miss after hamstring injury length revealed

Add as preferred source on Google

Destiny Udogie is set to miss six more matches for Tottenham Hotspur as he continues to recover from a hamstring injury.

The defender was forced off with the issue against Wolves back in late December and has already been sidelined for seven games.

Udogie is one of 14 Tottenham players who will be unavailable for the trip to Hoffenheim in the Europa League and the fourth who is currently struggling with a hamstring injury.

Djed Spence has done a great job filling in for the Italian defender although having Udogie back will be a big boost for Ange Postecoglou’s limited squad.

Which six Tottenham matches will Destiny Udogie miss with hamstring

Destiny Udogie is expected to return from injury in just over three weeks and will miss six matches during that period, according to Paul O’Keefe.

The first of six games is against Hoffenheim in a crucial Europa League match as they look to finish in the top eight of the group stages.

The 22-year-old will also miss their next Premier League clash against Leicester City which could be key for Ange Postecoglou’s future.

Postecoglou is in no immediate danger of the sack, however, a poor result against the Foxes and his hopes of keeping his job will become very slim.

The other four fixtures he will miss come against Elfsborg, Brentford, Liverpool and Aston Villa in what could be a defining run of games for their season.

Are Tottenham going to sign anyone this month?

‘Nothing imminent’ is the message from Paul O’Keefe in terms of Spurs bringing in new players this month.

The Lilywhites are in desperate need of reinforcement with Posteciglou’s squad having been decimated by injury, however, nothing might happen.

Tottenham fans were in despair following Postecoglou’s update and are deeply concerned about their hopes for the remainder of the season.

Tottenham tried to sign Randal Kolo Muani but missed out on a deal to Juventus and an alterative has not yet been identified.